Journal
THERAPEUTIC DELIVERY
Volume 3, Issue 7, Pages 889-900Publisher
FUTURE SCI LTD
DOI: 10.4155/TDE.12.68
Keywords
-
Categories
Ask authors/readers for more resources
This review summarizes the various challenges in product development involved in subcutaneous administration of high-dose monoclonal antibodies and attempts to provide an industry perspective of some of the available technologies and potential avenues to overcome these challenges.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available